Demo Sign up Log In

Crispr Therapeutics Ag (CRSP)

Cash Conversion Ratio

0.95×

Quarterly · Period ending: Jun 30, 2026

CRSP Cash Conversion Ratio

Latest reported0.95×period endingJun 30, 2026

Latest reported0.95×period endingJun 30, 2026

CRSP Quarterly Cash Conversion Ratio (-5.58× → 0.95×)

Latest values, visible window

High-resolution chart · PNG

CRSP cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	0.9502×
Mar 31, 2026	0.8899×
Dec 31, 2025	0.7126×
Sep 30, 2025	0.7958×
Jun 30, 2025	0.5466×
Mar 31, 2025	0.3982×
Dec 31, 2024	1.3477×
Sep 30, 2024	1.2466×
Jun 30, 2024	0.7617×
Mar 31, 2024	-0.9352×
Dec 31, 2023	-1.0835×
Jun 30, 2023	1.7597×
Mar 31, 2023	-0.1082×
Dec 31, 2022	1.0809×
Sep 30, 2022	0.6373×
Jun 30, 2022	0.8157×
Mar 31, 2022	0.8403×
Dec 31, 2021	0.6741×
Sep 30, 2021	0.931×
Jun 30, 2021	1.0255×
Mar 31, 2021	0.9516×
Dec 31, 2020	0.817×
Sep 30, 2020	0.8787×
Jun 30, 2020	0.4128×
Mar 31, 2020	0.7911×
Dec 31, 2019	0.0794×
Sep 30, 2019	0.9461×
Jun 30, 2019	0.718×
Mar 31, 2019	0.9262×
Dec 31, 2018	0.6172×
Sep 30, 2018	0.4074×
Jun 30, 2018	0.6706×
Mar 31, 2018	0.8213×
Dec 31, 2017	-106.7163×
Sep 30, 2017	0.7634×
Jun 30, 2017	0.7755×
Mar 31, 2017	1.2432×
Dec 31, 2016	-1.1489×
Sep 30, 2016	0.9381×
Jun 30, 2016	0.8536×
Mar 31, 2016	1.2137×
Dec 31, 2015	-5.5755×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.